Vanguard Capital Wealth Advisors
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1730578
DENVER, CO
Position in ARWR
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$716,065
+$164,305 QoQ
Shares Held
8,785
-0.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#271
of 499 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard Capital Wealth Advisors holds $1,003,641 across 3 Biotechnology names. ARWR ranks #1 (71.3% of the industry book) .
All Filings in ARWR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $716,065 | 8,785 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $551,760 | 8,800 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $626,987 | 9,444 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $389,219 | 11,285 | Shares | Sole | 2025-10-30 | |
| 2023-06-30 | $218,774 | 6,135 | Shares | Sole | 2023-11-01 | |
| 2022-12-31 | $301,563 | 7,435 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $291,996 | 8,835 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $321,643 | 9,135 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $424,717 | 9,235 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $666,248 | 10,049 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $680,424 | 10,899 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $894,373 | 10,799 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $735,974 | 11,099 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $939,865 | 12,249 | Shares | Sole | 2021-01-25 | |
| 2020-06-30 | $602,457 | 13,949 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||